For all of the benefit that radiopharmaceuticals offer, these treatments currently address a limited number of cancer targets. Aktis Oncology has technology that could broaden the reach of this type ...

Human relationships are and always will be the crux of meaningful customer engagements in the pharmaceutical industry. No channel rivals the impact of a well-prepared, well-supported representative.

Cancer care company Color Health is partnering with insurer Evry Health to enhance employer health plans with its cancer care services, according to a Wednesday announcement. Evry Health is a ...

Metabolic medicines continue to be one of the hottest areas for drug research, so it should come as no surprise that deal flow for obesity and diabetes drugs was a particular highlight of biopharma ...

Even with significant educational efforts, heart disease remains the leading cause of death in the US and worldwide—for both men and women. While statins are the standard of care, Esperion ...

Navigating inefficient payment processes has become one of the biggest pain points for patients. A recent study shows that more than half of U.S. patients report encountering confusion, errors, or ...

As demand for GLP-1s skyrockets, employers are struggling with the cost to cover these expensive medications for their employees. That’s why the Peterson Health Technology Institute, an independent ...

According to one expert at Pitchbook, two core issues are likely to dominate healthcare reform discussions in 2026: rising costs and flaws in Medicare Advantage. Healthcare affordability remains a ...

Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding ...

The healthcare industry could undergo significant changes in 2026, particularly regarding digital health, AI and cost challenges. That’s according to three VCs from LRVHealth, a healthcare venture ...

New research emerged this month shining light on the need for wider use of continuous glucose monitors (CGMs). The study — which was conducted by CCS, a chronic care management company — analyzed data ...

Across the healthcare industry, patients are demanding more transparency. They want control over their health and access to their healthcare data. And they’re right – patients should be at the center ...